Programme

Day 1: Weds 10th September

12:00

Registration and Lunch        

13:00 

Welcome Address: 

Session 1:     Antibody Immunotherapy (Session chair: Mark Cragg)
 

13:15  

Simon Davis (Oxford, UK)

Leveraging the kinetic - segregation model of receptor triggering for immunotherapy

13:45

Sophia Karagiannis (London, UK)

Antibodies for cancer therapy designed to take account of the patient immune contexture

14:15

ECR Abstract 1 - Isabel Elliott

14:30  

ECR Abstract 2 - Emmanuella Batu

14:45 

ECR Abstract 3 - Marcus Widdess

15:00

Promega talk

15:05    

Coffee Break     

15:45

Ingrid Teige (BioInvent, Lund, Sweden)
 

16:15   

Falk Nimmerjahn (Erlangen, Germany)

Cytotoxic IgG activity revisited:  How IgG antibodies kill target cells in vivo

16:45  

ECR Abstract 4 - Robert Oldham

17:00

Absolute Antibodies Talk

17:05     

Drinks reception & Poster session   

19:30  

Speakers' Dinner 

Day 2: Thursday 11th September

Session 2:     Technological advances for unpicking cancer immunology (Session chair: Sally Ward & Raimund J Ober)

9:15       

Christoph Wuelfing (Bristol, UK)    

The regulation of suppression of primary human cytotoxic T cells  

9:45      

Dr Tanmay Mitra (Oxford, UK)   

The regulation of suppression of primary human cytotoxic T cells  

10:15    

ECR Abstract 5 - Walaa Aburayan

10:30     

ECR Abstract 6 - Benjamin Jenkins

10:45   

Parse Talk

10:50    

Coffee Break

11:30

Pavel Tolar (London, UK)

IgG mutations associated with class-switched lymphomas.

12:00

Sripad Ram, (Pfizer, San Diego, USA)

Quantitative characterization of immune-cell infiltration patterns in human and murine tumor specimens

12:30

ECR Abstract 7 - Amatta Mirandari

12:45

Lunch

13:30

Poster session 2 (ends 14:15)

 Session 3:     Cellular Therapies (Session chair: Matt Blunt)

14:15 

Rizwan Romee (Boston, USA)

Novel cytokine engineering approaches to overcome immune suppressive tumour Microenvironment

14:45

Astero Klampatsa, PhD (ICR, London)

Targeting TME immunosuppression with CAR-T cells: effects and limitations

15:15   

ECR Abstract 8 - Soura Chakraborty

15:30   

ECR Abstract 9 - Abhishek Tomar

15:45  

Coffee Break  

16:15   

Fiona Thistlethwaite (Manchester, UK)

Real-world delivery of Cell Therapies for Solid Tumours'

16:45 

Karl-Johan Malmberg (Oslo, Norway/Stockholm, Sweden)  

Guiding the innate power of natural killer cells in cancer therapy

17:15

ECR Abstract 10 - Nurdan Aksoy Kilinc

17:30:00    

Drinks reception & Poster session 3

19:00:00     

Conference Dinner    

Day 3:          Friday 12th September

Session 4:     Translating ideas to the clinic (Session chair: Sean Lim)

9:30   

Christian Klein (Schlieren, Switzerland)

Monoclonal and bispecific antibodies: From idea to preclinical development and approval

10:00   

Andy Sewell (Cardiff, Wales)

Decoding Complete Remission:  What Successful T-Cells Can Teach Us About Cancer Treatment

10:30

ECR Abstract 11 - Christopher Jones

10:45

ECR Abstract 12 - Jiabao Zhou

11:00  

Immunotherapy advances (BSI Journals talk)   

11:05 

Coffee Break

11:30 

Linda Wooldridge (Bristol)

Understanding and improving the T-cell response to cancer 

12:00 

ECR Abstract 13 - Maryam Alismail

12:15     

Sean Lim (Southampton)

Optimising agonistic antibodies for anti-cancer therapy

12:45    

Closing remarks and prizes    

13:00 

Packed lunch to take away, departure.